检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:阎丽[1] 宋迎[1] YAN Li;SONG Ying(Department of General Medicine,Tianjin Fifth Central Hospital,Tianjin 300450,China)
机构地区:[1]天津市第五中心医院全科医学科,天津300450
出 处:《医学信息》2022年第19期155-158,共4页Journal of Medical Information
摘 要:2型糖尿病肾病是导致终末期肾衰竭的主要原因,及时评估其病情进展,同时给予积极干预,是延迟并控制终末期肾病的重要方式。甲状腺激素作为内分泌领域常见指标,现已有研究证实,该指标与2型糖尿病肾病的发生发展存在密切相关。其中,糖尿病肾病进展是引起甲状腺激素变化的重要原因,而甲状腺激素异常是导致糖尿病肾病进展的独立危险因素。本文结合2型糖尿病肾病的分期标准,针对甲状腺激素与不同阶段2型糖尿病肾病的相关性作一综述,以期为临床诊治该病提供参考。Type 2 diabetic nephropathy is the main cause of end-stage renal failure.Timely assessment of its progression and active intervention are important ways to delay and control end-stage renal disease.As a common index in the field of endocrine,thyroid hormone has been proved to be closely related to the occurrence and development of type 2 diabetic nephropathy.Among them,the progress of diabetic nephropathy is an important cause of thyroid hormone changes,and thyroid hormone abnormalities are independent risk factors leading to the progress of diabetic nephropathy.Based on the staging criteria of type 2 diabetic nephropathy,this paper reviews the correlation between thyroid hormone and type 2 diabetic nephropathy in different stages,in order to provide reference for clinical diagnosis and treatment of the disease.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.31